Hyperparathyroidism in a patient with autoimmune polyglandular syndrome

Internal Medicine

Volumn 47, Issue 21, 2008, Pages 1911-1915

  Pelletier Morel, Lorraine ^a   Fabien, Nicole ^b   Mouhoub, Yamina ^a   Boitard, Christian ^a,c   Larger, Etienne ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

Author keywords

Autoimmune polyglandular syndrome; Calcium sensing receptor autoantibodies; Diabetes; Hypercalcemia; Thyroiditis; Type 1

Indexed keywords

AUTOANTIBODY; CALCIUM; CALCIUM SENSING RECEPTOR; CARBIMAZOLE; GLUTAMATE DECARBOXYLASE ANTIBODY; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PANCREAS ISLET CELL ANTIBODY; PARATHYROID HORMONE; PARIETAL CELL ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CASE REPORT; CLINICAL FEATURE; GRAVES DISEASE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE RELEASE; PARATHYROID SCINTISCANNING; THYROID SCINTISCANNING;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 56349111846     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1355     Document Type: Article

References (20)

1. Thakker RV, Diseases associated with the extracellular Calcium-sensing receptor. Cell Calcium 35: 275-282, 2004.
2. Chou YH, Brown EM, Levi T, et al. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1: 295-300, 1992.
3. Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993.
4. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N, Autoantobodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97: 910-914, 1996.
5. Mayer A, Ploix C, Orgiazzi J, et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab 89: 4484-4488, 2004.
6. Gavalas NG, Kemp EH, Krohn KJE, Brown EM, Watson PF, Weetman AP, The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1 10.1210/jc.2006-2466. J Clin Endocrinol Metab 92: 2107-2114. 2007.
7. Alimohammadi M, Bjorklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358: 1018-1028, 2008.
8. Kifor O, Moore FD Jr., Delaney M, et al. A syndrome of hypocal ciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88: 60-72, 2003.
9. Pallais JC, Kifor O, Chen Y-B, Slovik D, Brown EM, Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351: 362-369, 2004.
10. Makita N, Sato J, Manaka K, et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. PNAS 104: 5443-5449, 2007.
11. Caillat-Zucman S, Garchon H-J, Timsit J, et al. Age-dependent HLA genetic heterogeneity of type I insulin-dependent diabetes mellitus. J Clin Invest 90: 2242-2250, 1992.
12. Fabien N, Moreira A, Lavergne JP, et al. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0. P1 and P2 proteins. J Autoimmun 13: 103-110, 1999.
13. Bilezikian JP, Silverberg SJ, Asymptomatic primary hyperparathyroidism. N Engl J Med 350: 1746-1751, 2004.
14. Jacobs TP. Bilezikian JP, Rare causes of hypercalcemia. J Clin Endocrinol Metab 90: 6316-6322, 2005.
15. Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L, Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcemia and primary hyperparathyroidism: A follow-up Study on methods. Clin Endocrinol (Oxf), in press, 2008.
16. Bilezikian JP, Potts JT Jr, Fuleihan GE-H, et al. Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century. J Clin Endocrinol Metab 87: 5353-5361, 2002.
17. Barker JM, Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening. J Clin Endocrinol Metab 91: 1210-1217, 2006.
18. Kifor O, McElduff A, LeBoff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 89: 548-556, 2004.
19. Taylor WH, Khaleeli AA, Prevalence of primary hyperparathyroidism in patients with diabetes-mellitus. Diabet Med 14: 386-389, 1997.
20. Khaleeli AA, Johnson JN, Taylor WH, Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev 23: 43-48, 2007.